Kodiak Sciences to Present at Upcoming Conferences

PALO ALTO, Calif.: PALO ALTO, Calif., Nov. 8, 2021 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high-prevalence retinal diseases, today announced that management will present at the following upcoming virtual investor conferences: Jefferies London Healthcare Conference (pre-recorded...

Click to view original post